ArticleCirculation. Population health and outcomes2026
Association Between Medicare Drug Plan Ratings and Coverage Barriers for Non-Generic, Evidence-Based Cardiovascular Medications.
Andrew Adelsheimer, Michael Hoffer-Hawlik, Nathalia Ladino, Samrachana Adhikari, Donglan Stacy Zhang, Allison P Squires, Adam N Berman, Stuart D Katz, Harmony R Reynolds, Saul Blecker and 1 more
Abstract readLetter
In one paragraphArticle in Circulation. Population health and outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Andrew AdelsheimerLeon H. Charney Division of Cardiology (A.A., A.N.B., S.K., H.R., A.M.), NYU Grossman School of Medicine.ORCID 0000-0002-0488-8145 Michael Hoffer-HawlikDepartment of Internal Medicine (M.H.-H., S.B.), NYU Grossman School of Medicine.ORCID 0000-0003-1701-3572 Nathalia LadinoNYU Grossman School of Medicine, Division of Healthcare Delivery Science, Department of Population Health (N.L., S.B., A.M.), NYU Grossman School of Medicine.
Samrachana AdhikariDivision of Biostatistics, Department of Population Health (S.A.), NYU Grossman School of Medicine.ORCID 0000-0001-9954-5999 Donglan Stacy ZhangDepartment of Foundations of Medicine, NYU Grossman Long Island School of Medicine (S.Z.).
Adam N BermanLeon H. Charney Division of Cardiology (A.A., A.N.B., S.K., H.R., A.M.), NYU Grossman School of Medicine.
Stuart D KatzLeon H. Charney Division of Cardiology (A.A., A.N.B., S.K., H.R., A.M.), NYU Grossman School of Medicine.ORCID 0000-0003-2340-2021 Harmony R ReynoldsLeon H. Charney Division of Cardiology (A.A., A.N.B., S.K., H.R., A.M.), NYU Grossman School of Medicine.ORCID 0000-0003-0284-0655 Amrita MukhopadhyayLeon H. Charney Division of Cardiology (A.A., A.N.B., S.K., H.R., A.M.), NYU Grossman School of Medicine.ORCID 0000-0002-7768-459X Funding
Impact of Restrictive Drug Coverage Policies on Heart Failure CareK23HL171636 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Amrita Mukhopadhyay · 2024 to 2026
$597kAmerican Heart Association-American Stroke Association 23CDA1042602NHLBI NIH HHS K23 HL171636
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anticoagulantsapixabancost sharingdapagliflozinrivaroxaban
Identifiers
PMID41686022
PMCPMC12905482
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390